Scroll up to People

Latest News

Cardurion Pharmaceuticals

PRESS RELEASE OCTOBER 27, 2021

Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital

PORTFOLIO NEWS JUNE 27, 2022

Tango therapeutics added to russell 2000®, 3000® and microcap® indexes

PORTFOLIO NEWS JUNE 20, 2022

X4 Pharmaceuticals Announces $55 Million Private Placement Financing and Debt Facility Amendment Extending Interest-Only Period by up to 12 Months

PORTFOLIO NEWS JUNE 16, 2022

Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President

PORTFOLIO NEWS JUNE 16, 2022

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

PORTFOLIO NEWS JUNE 15, 2022

Cerevel Therapeutics Announces Updates to its Board of Directors

PORTFOLIO NEWS JUNE 14, 2022

EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer

PORTFOLIO NEWS JUNE 13, 2022

Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS

PORTFOLIO NEWS JUNE 02, 2022

Freenome Continues Growth, Adds Three New Leaders

See all Life Sciences news >

Scroll down to Contact